Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 94851-94900 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04582916
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
PHASE1
Recruiting
64 participants
Started: Jul 20, 2021 · Completed: Apr 11, 2030
1 condition
1 sponsor
1 location
NCT05768698
Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography
N/A
Recruiting
20 participants
Started: Jul 20, 2021 · Completed: Jun 11, 2024
2 conditions
2 sponsors
1 location
NCT04860960
Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
PHASE3
Active, not recruiting
94 participants
Started: Jul 20, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
35 locations
NCT04789681
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
PHASE2
Recruiting
50 participants
Started: Jul 20, 2021 · Completed: Dec 31, 2025
13 conditions
1 sponsor
1 location
NCT04988451
Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL
NA
Active, not recruiting
40 participants
Started: Jul 20, 2021 · Completed: Nov 30, 2025
2 conditions
2 sponsors
1 location
NCT03914664
Neural Correlates of Sensory Phenomena in Tourette Syndrome
N/A
Enrolling by invitation
50 participants
Started: Jul 20, 2021 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT04629326
PD-L1 Targeting Molecular Imaging of Solid Tumors
NA
Recruiting
20 participants
Started: Jul 20, 2021 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT04775004
Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)
NA
Recruiting
146 participants
Started: Jul 19, 2021 · Completed: Mar 31, 2026
1 condition
2 sponsors
3 locations
NCT04409236
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
PHASE3
Active, not recruiting
427 participants
Started: Jul 19, 2021 · Completed: Sep 11, 2026
2 conditions
4 sponsors
1 location
NCT04476485
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
N/A
Recruiting
1,000 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
12 locations
NCT04920344
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
PHASE2
Active, not recruiting
15 participants
Started: Jul 19, 2021 · Completed: May 8, 2025
4 conditions
2 sponsors
3 locations
NCT04869436
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
PHASE4
Recruiting
27 participants
Started: Jul 19, 2021 · Completed: Dec 1, 2025
2 conditions
2 sponsors
1 location
NCT04798924
Visual Rehabilitation After Occipital Stroke
NA
Active, not recruiting
60 participants
Started: Jul 19, 2021 · Completed: Mar 15, 2026
14 conditions
2 sponsors
1 location
NCT04795219
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
N/A
Recruiting
1,250 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
3 conditions
2 sponsors
8 locations
NCT05712902
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
PHASE2
Active, not recruiting
104 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
33 locations
NCT04473066
Long-term Follow-up of Children With OSA Treated With AT
N/A
Recruiting
180 participants
Started: Jul 19, 2021 · Completed: Jul 31, 2024
1 condition
1 sponsor
2 locations
NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
PHASE1/PHASE2
Recruiting
540 participants
Started: Jul 19, 2021 · Completed: Apr 30, 2027
6 conditions
2 sponsors
49 locations
NCT04888429
Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma
PHASE2
Recruiting
28 participants
Started: Jul 19, 2021 · Completed: Jun 30, 2025
1 condition
2 sponsors
8 locations
NCT04947735
CYPRESS Efficacy and Safety Study Extension
NA
Active, not recruiting
200 participants
Started: Jul 19, 2021 · Completed: Mar 31, 2026
2 conditions
1 sponsor
12 locations
NCT04137653
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
PHASE3
Recruiting
1,498 participants
Started: Jul 19, 2021 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT04931485
Protocolised Early De-Resuscitation in Septic Shock (REDUCE)
NA
Active, not recruiting
170 participants
Started: Jul 19, 2021 · Completed: May 7, 2025
1 condition
1 sponsor
4 locations
NCT04615260
Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.
NA
Active, not recruiting
40 participants
Started: Jul 19, 2021 · Completed: Apr 30, 2025
2 conditions
1 sponsor
1 location
NCT04975763
Dietary Oils to Sustain Energy Study
NA
Active, not recruiting
16 participants
Started: Jul 19, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT04246879
MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases
NA
Active, not recruiting
25 participants
Started: Jul 19, 2021 · Completed: Mar 19, 2027
1 condition
1 sponsor
1 location
NCT04906759
Meal Delivery and Exercise
NA
Recruiting
100 participants
Started: Jul 19, 2021 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT04855552
Telehealth Weight Loss Program for Breast Cancer Survivors
NA
Active, not recruiting
22 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT04137640
Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
PHASE4
Not yet recruiting
152 participants
Started: Jul 19, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT04136782
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
PHASE4
Recruiting
110 participants
Started: Jul 19, 2021 · Completed: Nov 30, 2026
1 condition
1 sponsor
7 locations
NCT05074485
Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
PHASE1
Recruiting
70 participants
Started: Jul 19, 2021 · Completed: May 7, 2026
1 condition
2 sponsors
1 location
NCT04989439
Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants
N/A
Recruiting
10 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04775745
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
PHASE1
Recruiting
60 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
7 conditions
1 sponsor
4 locations
NCT06343428
Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients
N/A
Recruiting
20 participants
Started: Jul 19, 2021 · Completed: Jul 19, 2026
1 condition
1 sponsor
1 location
NCT04838678
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
EARLY_PHASE1
Recruiting
100 participants
Started: Jul 18, 2021 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06802887
Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study
N/A
Recruiting
12 participants
Started: Jul 18, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04284839
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
PHASE3
Recruiting
3,500 participants
Started: Jul 18, 2021 · Completed: Jun 30, 2027
2 conditions
2 sponsors
19 locations
NCT03843463
Escitalopram and Language Intervention for Subacute Aphasia
PHASE2
Recruiting
88 participants
Started: Jul 18, 2021 · Completed: Jan 18, 2027
2 conditions
5 sponsors
3 locations
NCT06330597
NIVIA-Hemodynamics
N/A
Recruiting
100 participants
Started: Jul 17, 2021 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT04511988
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal
NA
Active, not recruiting
20 participants
Started: Jul 17, 2021 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT04751877
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
PHASE3
Active, not recruiting
270 participants
Started: Jul 17, 2021 · Completed: Aug 17, 2027
2 conditions
3 sponsors
1 location
NCT04982588
Evolut PRO China Clinical Study
NA
Active, not recruiting
52 participants
Started: Jul 17, 2021 · Completed: May 15, 2028
1 condition
1 sponsor
4 locations
NCT04479735
Virtual Reality Goggle Utilization for Venipuncture Distraction
NA
Recruiting
200 participants
Started: Jul 16, 2021 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT04833465
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
N/A
Recruiting
90 participants
Started: Jul 16, 2021 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT03446287
Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms
N/A
Recruiting
150 participants
Started: Jul 16, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04868773
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
PHASE1
Active, not recruiting
12 participants
Started: Jul 16, 2021 · Completed: Feb 28, 2026
4 conditions
1 sponsor
1 location
NCT04586075
UW Undiagnosed Genetic Diseases Program
N/A
Recruiting
500 participants
Started: Jul 16, 2021 · Completed: Oct 31, 2030
3 conditions
2 sponsors
1 location
NCT05224739
Validate the Difficulty Scoring System and Develop a Novel Scoring System for Laparoscopic and Robotic Liver Resections
N/A
Enrolling by invitation
150 participants
Started: Jul 16, 2021 · Completed: Nov 16, 2024
1 condition
1 sponsor
1 location
NCT04680715
Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
PHASE2
Recruiting
40 participants
Started: Jul 16, 2021 · Completed: Jun 30, 2028
1 condition
1 sponsor
2 locations
NCT04911816
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
PHASE1/PHASE2
Recruiting
40 participants
Started: Jul 16, 2021 · Completed: Jun 30, 2030
1 condition
1 sponsor
1 location
NCT05120076
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy
PHASE3
Recruiting
60 participants
Started: Jul 16, 2021 · Completed: Aug 31, 2024
3 conditions
1 sponsor
1 location
NCT05024929
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
N/A
Recruiting
32 participants
Started: Jul 16, 2021 · Completed: Feb 1, 2033
3 conditions
2 sponsors
9 locations
Previous
1
More pages
1895
1896
1897
1898
1899
1900
1901
More pages
2369
Next